Haematological abnormalities and risk of COVID-19 infection in adult patients attending primary healthcare settings

  • Ehab Hamed | eshamed@phcc.gov.qa Qatar University Health Centre, Primary Health Care Corporation, Doha, Qatar. https://orcid.org/0000-0002-4404-1424
  • Mohamed Ahmed Syed Qatar University Health Centre, Primary Health Care Corporation, Doha, Qatar.
  • Ahmed Sameer Alnuaimi Qatar University Health Centre, Primary Health Care Corporation, Doha, Qatar.
  • Mohammed Soliman Qatar University Health Centre, Primary Health Care Corporation, Doha, Qatar.
  • Bayan Alemrayat Qatar University Health Centre, Primary Health Care Corporation, Doha, Qatar.
  • Amina Ali Mohamed Muktar Qatar University Health Centre, Primary Health Care Corporation, Doha, Qatar.
  • AlAnoud Saleh AlFehaidi Qatar University Health Centre, Primary Health Care Corporation, Doha, Qatar.
  • Hamda Abdulla AlQotba Qatar University Health Centre, Primary Health Care Corporation, Doha, Qatar.

Abstract

Centres for Disease Control and prevention (CDC) reports that there are limited data and information about the impact of underlying medical conditions and the risk of infection. To date, there are no studies that report on the risk of infection among patients with haematological diseases or abnormalities. This cross-sectional study reports on the baseline complete blood count in patients attending publicly funded primary care settings with a diagnosis of suspected COVID-19 infections in the state of Qatar. The study will report on the descriptive characteristics of the population, including gender, age and prior abnormalities to their blood test results. We will compare the results of those with positive and negative PCR test results, where appropriate. Nine hundred sixty-two adult patients attended publicly funded primary health care settings in the state of Qatar between February the 10th and April the 30th 2020 with a diagnosis of suspected COVID-19 infections had prior recorded blood investigations in the last six months and were included in this study. The population was young, mean of age is 38.8±11.6. (Median: 36 [Min: 19 - Max: 85]). Complete blood count of the sample had minimal missing data points. Females were more presented in our samples, Female (n=560, 58.21%) and Male (n=402, 41.79%). Most of our sample had a documented PCR test result, negative (n=831, 86.38%); positive (n=123, 12.79%) and missing (n=8, 0.83%). Low haemoglobin values (n=265, 27.5%) and low red blood cell count (n =170, 17.7%) were the most prevalent complete blood count abnormality in the population. Leukopenia was less common (n=50, 8.2%). Most of the population had normal platelet count (n=895, 93%). Gender was the most influential factor in our sample to increase the odds of having a positive PCR t results; males were more likely to be affected (P<0.001, Chi-square test) (OR 2.56, 95% CI 1.73-3.77). Categories for haematological abnormalities were not associated with increased risk of having a positive PCT test result. In a population attending primary healthcare settings with early presentation of symptoms of COVID-19 infection, the risk of infection among our cohort was not affected by the prior haematological values of those patients. Gender was the most influential parameter in the risk of infection in our population. Analysis of the results using gender-specific categories for different haematological parameters suggested that patients with abnormal haematological values were not at increased risk of having a positive COVID-19 infection.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

References

1. Centres for disease and control and prevention (CDC). Certain Medical Conditions and Risk for Severe COVID-19 Illness | CDC [Internet]. [cited 2020 Aug 3]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html
2. Almirall J, Serra-Prat M, Bolíbar I, Balasso V. Risk Factors for Community-Acquired Pneumonia in Adults: A Systematic Review of Observational Studies. Respiration [Internet]. 2017 Aug 1 [cited 2020 Aug 4];94(3):299–311. Available from: https://www.karger.com/Article/FullText/479089
3. Almirall J, Bolíbar I, Serra-Prat M, Roig J, Hospital I, Carandell E, et al. New evidence of risk factors for community-acquired pneumonia: A population-based study. Eur Respir J [Internet]. 2008 Jun 1 [cited 2020 Aug 4];31(6):1274–84. Available from: http://www.erj.ersjournals.com/current.shtml
4. Ramakrishnan M, Moïsi JC, Klugman KP, Iglesias JMF, Grant LR, Mpoudi-Etame M, et al. Increased risk of invasive bacterial infections in African people with sickle-cell disease: A systematic review and meta-analysis. Vol. 10, The Lancet Infectious Diseases. Elsevier; 2010. p. 329–37.
5. Motta I, Migone De Amicis M, Pinto VM, Balocco M, Longo F, Bonetti F, et al. SARS‐CoV ‐2 infection in beta thalassemia: Preliminary data from the Italian experience. Am J Hematol [Internet]. 2020 Aug 6 [cited 2020 Aug 3];95(8):E198–9. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/ajh.25840
6. Karimi M, Haghpanah S, Azarkeivan A, Zahedi Z, Zarei T, Akhavan Tavakoli M, et al. Prevalence and mortality in β-thalassaemias due to outbreak of novel coronavirus disease (COVID-19): the nationwide Iranian experience [Internet]. British Journal of Haematology. Blackwell Publishing Ltd; 2020 [cited 2020 Aug 3]. Available from: /pmc/articles/PMC7300954/?report=abstract
7. Nur E, Gaartman AE, Tuijn CFJ, Tang MW, Biemond BJ. Vaso‐occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease ( COVID ‐19). Am J Hematol [Internet]. 2020 Jun 21 [cited 2020 Aug 3];95(6):725–6. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/ajh.25821
8. Hussain FA, Njoku FU, Saraf SL, Molokie RE, Gordeuk VR, Han J. COVID‐19 infection in patients with sickle cell disease. Br J Haematol [Internet]. 2020 Jun 8 [cited 2020 Aug 3];189(5):851–2. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16734
9. Heilbronner C, Berteloot L, Tremolieres P, Dupic L, Saint Blanquat L, Lesage F, et al. Patients with sickle cell disease and suspected COVID‐19 in a paediatric intensive care unit. Br J Haematol [Internet]. 2020 Jul 8 [cited 2020 Aug 3];190(1):e21–4. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16802
10. McCloskey KA, Meenan J, Hall R, Tsitsikas DA. COVID‐19 infection and sickle cell disease: a UK centre experience. Br J Haematol [Internet]. 2020 Jul 17 [cited 2020 Aug 3];190(2):e57–8. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16779
11. Härter G, Spinner CD, Roider J, Bickel M, Krznaric I, Grunwald S, et al. COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients. Infection [Internet]. 2020 [cited 2020 Aug 3];14:1. Available from: /pmc/articles/PMC7211976/?report=abstract
12. Altuntas Aydin O, Kumbasar Karaosmanoglu H, Kart Yasar K. HIV/SARS‐CoV‐2 coinfected patients in Istanbul, Turkey. J Med Virol [Internet]. 2020 Jun 3 [cited 2020 Aug 3];jmv.25955. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.25955
13. Gao Y, Chen Y, Liu M, Shi S, Tian J. Impacts of immunosuppression and immunodeficiency on COVID-19: A systematic review and meta-analysis. J Infect [Internet]. 2020 [cited 2020 Aug 3];81:e93–5. Available from: https://doi.org/10.1016/j.jinf.2020.05.017
14. Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clin Chim Acta [Internet]. 2020 Jul 1 [cited 2020 Aug 3];506:145–8. Available from: https://pubmed.ncbi.nlm.nih.gov/32178975/
15. Jiang SQ, Huang QF, Xie WM, Lv C, Quan XQ. The association between severe COVID-19 and low platelet count: evidence from 31 observational studies involving 7613 participants. Vol. 190, British Journal of Haematology. Blackwell Publishing Ltd; 2020. p. e29–33.
16. Eugene FAN B, Cui Lian CHONG V, Seok Wei CHAN S, Hsiang LIM G, Guan Eric LIM K, Bee TAN G, et al. Hematologic parameters in patients with COVID-19 infection [Internet]. American Journal of Hematology Wiley-Liss Inc.; Jun 1, 2020 p. E131–4. Available from: https://pubmed.ncbi.nlm.nih.gov/32129508/
17. Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, et al. Hematological findings and complications of COVID-19 [Internet]. Vol. 95, American Journal of Hematology. Wiley-Liss Inc.; 2020 [cited 2020 Aug 1]. p. 834–47. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/ajh.25829
18. Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med [Internet]. 2020 Jun 25 [cited 2020 Aug 1];58(7):1021–8. Available from: https://doi.org/10.1515/cclm-2020-0369
19. Hamed E, Abd Elhamid M, Alemrayat B. Suspected cases of COVID-19: study protocol for reporting characteristics and the outcomes. Fam Med Community Heal [Internet]. 2020 Apr 26 [cited 2020 Aug 3];8(2):400. Available from: https://fmch.bmj.com/content/8/2/e000400
20. AlFehaidi AS, Mohamed ZAK, Abd Elhamid M, Alemrayat B, Hamed E. Why do we need to report on COVID-19 suspected cases presentation in primary care? Int J Community Med Public Heal [Internet]. 2020 May 27 [cited 2020 Aug 3];7(6):2431. Available from: http://www.ijcmph.com
Published
2020-11-17
Info
Issue
Section
Original Articles
Keywords:
COVID-19, Risk Factors, Haematology
Statistics
  • Abstract views: 337

  • PDF: 155
  • HTML: 0
How to Cite
Hamed, E., Syed, M. A., Alnuaimi, A. S., Soliman, M., Alemrayat, B., Muktar, A. A. M., AlFehaidi, A. S., & AlQotba, H. A. (2020). Haematological abnormalities and risk of COVID-19 infection in adult patients attending primary healthcare settings. Hematology Reports, 12(2). https://doi.org/10.4081/hr.2020.8829